This review outlines critical knowledge gaps regarding African Swine Fever Virus (ASFV) vectors, vaccine development, and importation risks in the United States.
Highlights ASFV knowledge gaps for US swine; leaves open vector- and vaccine-targeted risk mitigation pending targeted studies.
ticks that have yet to be characterized would be useful to understand vector competence, host preferences, and distribution of competent soft tick vectors in relation to high pig production areas as well as regions with high feral swine (wild boar or similar) densities. Knowledge relative to antigenic viral proteins that contribute to host response and determination of immune mechanisms that lead to protection are foundational in the quest for a vaccine. Finally, sampling of illegally imported and confiscated wild suid products for ASFV could shed light on the types of products being imported and provide a more informed perspective relative to the risk of ASFV importation.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: